|
|
|
|
| LEADER |
03081nma a2201045 u 4500 |
| 001 |
EB001992187 |
| 003 |
EBX01000000000000001155089 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
210512 ||| eng |
| 020 |
|
|
|a books978-3-03936-307-0
|
| 020 |
|
|
|a 9783039363070
|
| 020 |
|
|
|a 9783039363063
|
| 100 |
1 |
|
|a Torrado Durán, Juan José
|
| 245 |
0 |
0 |
|a Antifungal and Antiparasitic Drug Delivery
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel, Switzerland
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2020
|
| 300 |
|
|
|a 1 electronic resource (168 p.)
|
| 653 |
|
|
|a virulence
|
| 653 |
|
|
|a solubility
|
| 653 |
|
|
|a Sporothrix schenckii
|
| 653 |
|
|
|a topical treatment
|
| 653 |
|
|
|a wound dressing
|
| 653 |
|
|
|a Amphotericin B
|
| 653 |
|
|
|a Molecular Envelope Technology
|
| 653 |
|
|
|a enolase
|
| 653 |
|
|
|a butenafine
|
| 653 |
|
|
|a Sepigel 305®
|
| 653 |
|
|
|a Lentinula edodes
|
| 653 |
|
|
|a cutaneous leishmaniasis
|
| 653 |
|
|
|a chitosan
|
| 653 |
|
|
|a combined therapy
|
| 653 |
|
|
|a transferosomes
|
| 653 |
|
|
|a praziquantel
|
| 653 |
|
|
|a azoles
|
| 653 |
|
|
|a Poly(d,l-lactide-co-glycolide) beads
|
| 653 |
|
|
|a design of experiments
|
| 653 |
|
|
|a sustained release
|
| 653 |
|
|
|a spray drying
|
| 653 |
|
|
|a malaria
|
| 653 |
|
|
|a fast-dissolving films
|
| 653 |
|
|
|a candidiasis
|
| 653 |
|
|
|a trypanosomiasis
|
| 653 |
|
|
|a micelles
|
| 653 |
|
|
|a AHCC®
|
| 653 |
|
|
|a orodispersible films
|
| 653 |
|
|
|a fluconazole
|
| 653 |
|
|
|a aspergillosis
|
| 653 |
|
|
|a solid SNEDDS
|
| 653 |
|
|
|a Montanide PetGel A
|
| 653 |
|
|
|a orthopedic infection
|
| 653 |
|
|
|a meglumine antimoniate
|
| 653 |
|
|
|a polymer micelles
|
| 653 |
|
|
|a SNEDDS
|
| 653 |
|
|
|a oral delivery
|
| 653 |
|
|
|a amphotericin B
|
| 653 |
|
|
|a leishmaniasis
|
| 653 |
|
|
|a toluene
|
| 653 |
|
|
|a schistosomiasis
|
| 653 |
|
|
|a poloxamer 407
|
| 653 |
|
|
|a controlled release
|
| 653 |
|
|
|a quality by design
|
| 653 |
|
|
|a emulsions
|
| 653 |
|
|
|a nanoparticles
|
| 653 |
|
|
|a calcium carbonate
|
| 653 |
|
|
|a adjuvants
|
| 653 |
|
|
|a vaccine
|
| 653 |
|
|
|a thermoreversible gel
|
| 653 |
|
|
|a fungal infections
|
| 653 |
|
|
|a Leishmania infantum
|
| 653 |
|
|
|a liposomes
|
| 653 |
|
|
|a cytotoxicity
|
| 653 |
|
|
|a skin and vaginal mucosa
|
| 653 |
|
|
|a hydrogel
|
| 653 |
|
|
|a shiitake
|
| 653 |
|
|
|a drug delivery
|
| 653 |
|
|
|a bioavailability
|
| 653 |
|
|
|a Research and information: general / bicssc
|
| 700 |
1 |
|
|a Serrano, Dolores R.
|
| 700 |
1 |
|
|a Capilla, Javier
|
| 700 |
1 |
|
|a Torrado Durán, Juan José
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 024 |
8 |
|
|a 10.3390/books978-3-03936-307-0
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/2471
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/68705
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 000
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 600
|
| 520 |
|
|
|a undefined
|